Bausch Health
BHC
377 hedge funds and large institutions have $7.07B invested in Bausch Health in 2021 Q4 according to their latest regulatory filings, with 76 funds opening new positions, 109 increasing their positions, 112 reducing their positions, and 42 closing their positions.
81% more first-time investments, than exits
New positions opened: 76 | Existing positions closed: 42
29% more call options, than puts
Call options by funds: $368M | Put options by funds: $285M
11% more funds holding in top 10
Funds holding in top 10: 19 → 21 (+2)
9% more funds holding
Funds holding: 346 → 377 (+31)
1.26% more ownership
Funds ownership: 70.27% → 71.53% (+1.3%)
0% more capital invested
Capital invested by funds: $7.04B → $7.07B (+$29.7M)
3% less repeat investments, than reductions
Existing positions increased: 109 | Existing positions reduced: 112
Top Buyers
| 1 |
Nomura Holdings
Tokyo,
Japan
|
+$96.7M |
| 2 |
PIP
Permian Investment Partners
Dallas,
Texas
|
+$61.6M |
| 3 |
LCM
Laurion Capital Management
New York
|
+$57.6M |
| 4 |
B
BloombergSen
Toronto,
Ontario, Canada
|
+$43.5M |
| 5 |
Millennium Management
New York
|
+$33.9M |
Top Sellers
| 1 |
GAM
Goldentree Asset Management
New York
|
-$90.9M |
| 2 |
GCM
Glenview Capital Management
New York
|
-$84.2M |
| 3 |
VH
ValueAct Holdings
San Francisco,
California
|
-$62.2M |
| 4 |
ClearBridge Investments
New York
|
-$49.3M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$39.1M |
BHC Hedge Fund Activity: Q4 2021 in Review
377 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Bausch Health (BHC) for Q4 2021, worth a combined $7.07B — up 0.42% from $7.04B a quarter earlier.
Buyers outnumbered sellers: 76 funds opened new BHC positions and 42 closed out — a net gain of 34 holders — while 109 added to existing stakes and 112 trimmed.
The largest buyer was Nomura Holdings, adding an estimated $96.7M. The largest seller was Goldentree Asset Management, cutting an estimated $90.9M.
- 377 institutional investors held Bausch Health (BHC) as of Q4 2021, up from 346 in Q3 2021.
- Funds reported $7.07B of Bausch Health stock for Q4 2021, up 0.42% quarter-over-quarter.
- 76 funds opened new Bausch Health positions in Q4 2021 and 42 closed out, a net change of +34 holders.
- The largest Bausch Health buyer in Q4 2021 was Nomura Holdings, an estimated $96.7M added.
- The largest Bausch Health seller in Q4 2021 was Goldentree Asset Management, an estimated $90.9M sold.
Based on aggregated 13F filings for Q4 2021.